99 related articles for article (PubMed ID: 24429780)
1. [Toxicity modifying action of remaxol by treatment of advanced oral cancer].
Matiakin GG; Ivanov VM; Ivanova OV; Sheĭkin MM
Stomatologiia (Mosk); 2013; 92(6):12-5. PubMed ID: 24429780
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial.
Huang BS; Wu SC; Lin CY; Fan KH; Chang JT; Chen SC
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12819. PubMed ID: 29315944
[TBL] [Abstract][Full Text] [Related]
3. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.
Lambrecht M; Mercier C; Geussens Y; Nuyts S
Support Care Cancer; 2013 Oct; 21(10):2663-70. PubMed ID: 23686379
[TBL] [Abstract][Full Text] [Related]
4. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
Liang G; Du W; Ke Q; Huang B; Yang J
Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
[TBL] [Abstract][Full Text] [Related]
5. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
6. [Radiation-induced mucositis and neutrophil granulocytes in oral mucosa].
Schmidberger H; Rave-Fränk M; Kim S; Hille A; Pradier O; Hess CF
Strahlenther Onkol; 2003 Oct; 179(10):667-72. PubMed ID: 14566474
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of an ayurvedic preparation of yashtimadhu (
Mamgain RK; Gupta M; Mamgain P; Verma SK; Pruthi DS; Kandwal A; Saini S
J Cancer Res Ther; 2020; 16(3):458-462. PubMed ID: 32719251
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data.
Quinn B
Eur J Cancer Care (Engl); 2013 Sep; 22(5):564-79. PubMed ID: 23731197
[TBL] [Abstract][Full Text] [Related]
10. A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders.
Hewlings S; Kalman D
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121367
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of Oro-T oral rinse in oral mucositis during cancer radiotherapy and/or chemotherapy: Cumulative analysis of two studies.
Koushik K; Janaki MG; Kumawat R; Paramesh R; Palaniyamma D
J Cancer Res Ther; 2021; 17(6):1503-1509. PubMed ID: 34916385
[TBL] [Abstract][Full Text] [Related]
12. The effect of a calcium phosphate mouth rinse on (chemo) radiation induced oral mucositis in head and neck cancer patients: a prospective study.
Stokman MA; Burlage FR; Spijkervet FK
Int J Dent Hyg; 2012 Aug; 10(3):175-80. PubMed ID: 23046006
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Benefit of Placentrex in the Management of Acute Chemo Radiation Induced Mucositis in Oral Cancer Patients.
Kondaveeti SS; C V D; John C; M M; S R
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3099-3103. PubMed ID: 30486548
[TBL] [Abstract][Full Text] [Related]
14. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
[TBL] [Abstract][Full Text] [Related]
15. [Supportive therapy for locally advanced cancer of the oral mucosa].
Ivanov VM; Matiakin GG; Ivanova OV; Sheĭkin MV; Romantsov MG
Vopr Onkol; 2012; 58(6):749-53. PubMed ID: 23600298
[TBL] [Abstract][Full Text] [Related]
16. Protection from radiation-induced oral mucositis by a mouth rinse containing the prostaglandin E1 analog, misoprostol: a placebo controlled double blind clinical trial.
Hanson WR; Marks JE; Reddy SP; Simon S; Mihalo WE; Tova Y
Adv Exp Med Biol; 1997; 400B():811-8. PubMed ID: 9547633
[No Abstract] [Full Text] [Related]
17. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
[TBL] [Abstract][Full Text] [Related]
18. Sucralfate in radiation-induced mucositis.
Sur RK
S Afr Med J; 1997 Mar; 87(3):337-8. PubMed ID: 9137350
[No Abstract] [Full Text] [Related]
19. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.
Weisdorf DJ; Bostrom B; Raether D; Mattingly M; Walker P; Pihlstrom B; Ferrieri P; Haake R; Goldman A; Woods W
Bone Marrow Transplant; 1989 Jan; 4(1):89-95. PubMed ID: 2647192
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based oral care for oral mucositis.
Farrington M; Cullen L; Dawson C
ORL Head Neck Nurs; 2013; 31(3):6-15. PubMed ID: 24069711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
